Edition:
India

EyePoint Pharmaceuticals Inc (EYPT.OQ)

EYPT.OQ on NASDAQ Stock Exchange Global Market

2.65USD
19 Oct 2018
Change (% chg)

$-0.30 (-10.17%)
Prev Close
$2.95
Open
$2.94
Day's High
$2.94
Day's Low
$2.34
Volume
411,957
Avg. Vol
92,665
52-wk High
$3.94
52-wk Low
$0.93

Chart for

About

Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug delivery products primarily for the treatment of chronic eye diseases. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 39.32
Dividend: --
Yield (%): --

Financials

BRIEF-EyePoint Pharmaceuticals Reports Q3 Loss Per Share $0.15

* EYEPOINT PHARMACEUTICALS REPORTS FISCAL THIRD QUARTER 2018 RESULTS

09 May 2018

Earnings vs. Estimates